Adams-Oliver syndrome: genes and variants
Explore variant evidence for Adams-Oliver syndrome across 2 analyzed proteins (NOTCH1, NOTCH3). Linked ClinVar records include 10 pathogenic or likely pathogenic variants, 795 variants of uncertain significance and 516 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Adams-Oliver syndrome
NOTCH1: Neurogenic locus notch homolog protein 1
Ligand-dependent cleavage releases an intracellular domain that directly controls transcriptional programs governing cell fate and differentiation. Pathogenic variants can cause congenital aortic-valve disease and left-sided heart defects, while activating or inactivating somatic changes contribute to several cancers.
9 ClinVar pathogenic / likely pathogenic and 1,311 uncertain variants in NOTCH1 have source records linked to Adams-Oliver syndrome. Association strength is not clinical gene validity.
NOTCH3: Neurogenic locus notch homolog protein 3
Its signaling helps maintain vascular smooth-muscle and mural-cell identity in small arteries. Pathogenic cysteine-altering variants cause CADASIL, with migraine, recurrent ischemic strokes, white-matter disease, and progressive cognitive impairment.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in NOTCH3 have source records linked to Adams-Oliver syndrome. Association strength is not clinical gene validity.
Where Adams-Oliver syndrome variants cluster
- NOTCH1 EGF-like 11 (positions 412–450): 3 of 9 ClinVar pathogenic / likely pathogenic variants, 21.8× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Adams-Oliver syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| NOTCH1 C1496Y | 1496 | LNR 2 | Pathogenic / likely pathogenic (★★) |
| NOTCH1 D1517N | 1517 | LNR 2 | Pathogenic / likely pathogenic (★★) |
| NOTCH3 C65S | 65 | EGF-like 1 | Pathogenic / likely pathogenic (★★) |
| NOTCH1 R448Q | 448 | EGF-like 11 | Pathogenic / likely pathogenic (★) |
| NOTCH1 C449R | 449 | EGF-like 11 | Pathogenic / likely pathogenic (★) |
| NOTCH1 C456Y | 456 | EGF-like 12 | Pathogenic / likely pathogenic (★) |
| NOTCH1 Y670C | 670 | EGF-like 17 | Pathogenic / likely pathogenic (★) |
| NOTCH1 C1094Y | 1094 | EGF-like 28 | Pathogenic / likely pathogenic (★) |
| NOTCH1 C1374R | 1374 | EGF-like 35 | Pathogenic / likely pathogenic (★) |
| NOTCH1 C429R | 429 | EGF-like 11 | Pathogenic / likely pathogenic |
Which prediction tools work for Adams-Oliver syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 98 out of 100
- MetaLR: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 91 out of 100
- SIFT: 88 out of 100
Same protein, different disease
- CADASIL also has ClinVar records linked to NOTCH3 variants; they fall mostly in different places as the Adams-Oliver syndrome variants (89 pathogenic / likely pathogenic).
- Lateral meningocele syndrome also has ClinVar records linked to NOTCH3 variants; they fall mostly in different places as the Adams-Oliver syndrome variants (12 pathogenic / likely pathogenic).
- Myofibromatosis also has ClinVar records linked to NOTCH3 variants; they fall mostly in different places as the Adams-Oliver syndrome variants (12 pathogenic / likely pathogenic).
Diseases related to Adams-Oliver syndrome
- Familial thoracic aortic aneurysm and aortic dissection, also linked to NOTCH1
- CADASIL, also linked to NOTCH3
- Connective tissue disease, also linked to NOTCH1
- Myofibromatosis, also linked to NOTCH3
- Auditory neuropathy, also linked to NOTCH3
- Lateral meningocele syndrome, also linked to NOTCH3
- Aortic valve disease, also linked to NOTCH1
- Migraine, also linked to NOTCH3
- Head and neck squamous cell carcinoma, also linked to NOTCH1
- Ischemic stroke, also linked to NOTCH3
Frequently asked questions
Which genes have records linked to Adams-Oliver syndrome?
This view contains 2 analyzed proteins: NOTCH1, NOTCH3. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 10 pathogenic or likely pathogenic variants, 795 variants of uncertain significance and 516 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 1,576 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center